Cover Image
市場調查報告書

心肌病:全球臨床實驗檢討

Cardiomyopathy Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 167035
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
心肌病:全球臨床實驗檢討 Cardiomyopathy Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月12日 內容資訊: 英文 76 Pages
簡介

本報告提供心肌病相關臨床研究的最新趨勢相關分析,為您彙整疾病治療方法概要,及臨床實驗的主要國家,G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 心肌病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國對臨床實驗數量:心血管系統疾病臨床實驗數量上,心肌病臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國(新興7國)對臨床實驗數量:心血管系統疾病臨床實驗數量上,心肌病臨床實驗數量所佔的比例

E7各國(新興7國)臨床實驗數量:Phase別

E7各國(新興7國)臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Johnson & Johnson
    • Gilead Sciences, Inc.
    • Pfizer Inc.
    • Les Laboratoires Servier SAS
    • Celladon Corporation
    • Aastrom Biosciences, Inc.
    • Bayer AG
    • Array BioPharma Inc.
    • AAVLife
    • A. Menarini Industrie Farmaceutiche Riunite Srl
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • University of Pittsburgh
    • Johns Hopkins University
    • Assistance Publique - Hopitaux de Paris
    • University of Michigan
    • 大阪大學
    • Maastricht University Medical Center
    • University Health Network
    • Johann Wolfgang Goethe University Hospitals
    • Stanford University

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cardiomyopathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cardiomyopathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cardiomyopathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Les Laboratoires Servier SAS
      • Clinical Trial Overview of Les Laboratoires Servier SAS
      • Celladon Corporation
      • Clinical Trial Overview of Celladon Corporation
      • Aastrom Biosciences, Inc.
      • Clinical Trial Overview of Aastrom Biosciences, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Array BioPharma Inc.
      • Clinical Trial Overview of Array BioPharma Inc.
      • AAVLife
      • Clinical Trial Overview of AAVLife
      • A. Menarini Industrie Farmaceutiche Riunite Srl
      • Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • University of Michigan
      • Clinical Trial Overview of University of Michigan
      • Osaka University
      • Clinical Trial Overview of Osaka University
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • Johann Wolfgang Goethe University Hospitals
      • Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cardiomyopathy Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Cardiomyopathy Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Celladon Corporation, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AAVLife, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top